undamentalytics Newsletter
Sign in

Idexx Laboratories revenue

Idexx Laboratories's revenue was $4.30bn in fiscal 2025, up 10.4% on the year before. Since fiscal 2009 ($1.03bn) it has grown at a compound 9.3% a year. Over the last twelve months it was $4.66bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1,0321,1031,2191,2931,3771,4861,6021,7751,9692,2132,4072,7073,2153,3673,6613,8984,3044,662
Growth on the year before—+7.0%+10.4%+6.1%+6.5%+7.9%+7.8%+10.8%+10.9%+12.4%+8.8%+12.5%+18.8%+4.7%+8.7%+6.5%+10.4%—
Gross profit5265796476997568168909751,0971,2421,3661,5711,8892,0042,1902,3792,6602,924
Gross margin51.0%52.4%53.0%54.1%54.9%54.9%55.6%54.9%55.7%56.1%56.7%58.0%58.8%59.5%59.8%61.0%61.8%62.7%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $2.5B 59.0% ▲ 12.9%
Services $1.8B 41.0% ▲ 7.0%
Geography
Region Revenue YoY
Americas $3B ▲ 8.7%
United States $2.8B ▲ 8.7%
EMEA $937M ▲ 16.2%
Asia Pacific $356M ▲ 10.9%
Europethe Middle East and Africa Other $230M ▲ 17.2%
Germany $207M ▲ 19.0%
Canada $167M ▲ 9.4%
United Kingdom $154M ▲ 14.7%
France $126M ▲ 13.7%
Asia Pacific Other $124M ▲ 13.0%
Australia $112M ▲ 10.1%
Latin America and Caribbean $90.4M ▲ 8.0%
Japan $83.4M ▲ 14.0%
ES $71M ▲ 14.7%
IT $66.9M ▲ 14.8%
Switzerland $41.7M ▲ 12.1%
Netherlands $40.5M ▲ 19.0%
China $36M ▲ 0.4%

These categories overlap or exclude eliminations, so shares aren't shown.

From Idexx Laboratories's 10-K filed February 20, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Idexx Laboratories $4.66bn 11.9% 9.1%
Dexcom $5.10bn 13.0% 14.5%
Bausch & Lomb Corp $5.42bn 8.9% 10.9%
ResMed| $5.73bn 9.0% 9.4%
Steris $6.04bn 8.4% 9.0%
Edwards Lifesciences $6.51bn 14.6% 15.3%

Compare with peers

Head to head: DXCM vs IDXXBLCO vs IDXXIDXX vs RMD

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Idexx Laboratories's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Idexx Laboratories.